Clinical Trials on High Risk Prostate Cancer in Finland
Total 216 results
-
Turku University HospitalUniversity of TurkuCompleted
-
Turku University HospitalRecruitingProstate Cancer | Localized Prostate Carcinoma | Intermediate Risk Prostate Cancer | Castration-Naive Prostate CancerFinland
-
Turku University HospitalUniversity of TurkuActive, not recruitingBenign Prostatic Hyperplasia | Locally Advanced Prostate Cancer | Locally Recurrent Prostate Cancer | Localised Prostate CancerFinland
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Kuopio University... and other collaboratorsCompletedMetastatic Prostate CancerFinland
-
AstraZenecaCompletedNon-Metastatic Prostate CancerFinland
-
Tampere UniversityFinnish Prostate Cancer GroupUnknownPatients With T1-4 Advanced Prostate CancerFinland
-
PfizerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC) | Metastatic Castration Sensitive Prostate Cancer (mCSPC)Finland
-
Turku University HospitalActive, not recruitingLocalized Prostate CancerFinland
-
Turku University HospitalUnknown
-
Tampere University HospitalTampere UniversityNot yet recruitingProstate Cancer Recurrence After Radical ProstatectomyFinland
-
Turku University HospitalUniversity of TurkuRecruitingProstate Cancer | Prostate HyperplasiaFinland
-
Blue Earth DiagnosticsCompleted
-
Lidds ABCompleted
-
University of OuluOulu University HospitalCompleted
-
Tampere UniversityCompleted
-
Turku University HospitalRecruitingProstate CancerFinland
-
Tampere University HospitalSeinajoki Central HospitalActive, not recruiting
-
Turku University HospitalUniversity of TurkuCompleted
-
Turku University HospitalCompletedProstate CancerFinland
-
AstraZenecaCompleted
-
Helsinki University Central HospitalUniversity of HelsinkiRecruiting
-
Tampere UniversityLund University; University of Helsinki; Hospital District of Helsinki and Uusimaa and other collaboratorsEnrolling by invitation
-
Orion Corporation, Orion PharmaCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticFinland, France, Denmark
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsRecruitingRecurrent Prostate Cancer | Metastatic Prostate CancerFinland, Norway, Estonia, Denmark
-
Life Molecular Imaging SATerminatedProstate CancerAustria, Finland
-
Lidds ABUppsala UniversityCompletedProstate CancerFinland, Sweden
-
DexTech Medical ABUnknownProstate Cancer MetastaticEstonia, Sweden, Finland, Latvia
-
Turku University HospitalRecruiting
-
Kuopio University HospitalUnknownProstate CancerFinland
-
Turku University HospitalMemorial Sloan Kettering Cancer Center; Tampere University Hospital; Mount Sinai... and other collaboratorsRecruitingProstate CancerFinland
-
Helsinki University Central HospitalActive, not recruitingProstate CancerFinland
-
Turku University HospitalCompleted
-
Tampere University HospitalVaralan urheiluopistoUnknown
-
Ferring PharmaceuticalsCompletedProstate CancerFinland, France, Germany
-
Camurus ABCompletedPhase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate CancerProstate CancerFinland, Hungary
-
Turku University HospitalRecruitingProstatic Hyperplasia | Prostate CancerFinland
-
Turku University HospitalUnknown
-
National Human Genome Research Institute (NHGRI)Completed
-
BayerRecruitingMetastatic Castration-resistant Prostate CancerUnited Kingdom, Netherlands, Finland
-
Orion Corporation, Orion PharmaCompletedProstate CancerFinland, France, United Kingdom, Latvia
-
Life Molecular Imaging SACompleted
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Turku University HospitalUniversity of Turku; Academy of Finland; Foundation for Paediatric Research,... and other collaboratorsCompletedSubstance-Related Disorders | Depression | Anxiety | Pregnancy, High Risk | Parenting | Maternal-Fetal Relations | Prenatal Care | Fetal Exposure During Pregnancy | Perinatal OutcomeFinland
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
Scandinavian Prostate Cancer GroupUnknownProstate CancerFinland, Denmark, Iceland, Norway, Sweden
-
Brown UniversityBayer; The Miriam Hospital; Rhode Island Hospital; Clovis Oncology, Inc.Active, not recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Roger Williams Medical CenterSuspendedTrial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningProstate CancerUnited States
-
University Urological Associates Inc.Unknown
-
Brown UniversityThe Miriam Hospital; Rhode Island HospitalCompletedProstate CancerUnited States